地中海の集団におけるベータタラセミアの産前診断のための新しいDNAポリモルフィズム
Lancet (London, England)
|December 8, 1984
まとめ
ベータ・グロービン遺伝子の新しいAva II制限酵素ポリモルフィズムが特定されました. この発見は,DNA分析を用いた地中海人集団におけるベータタラセミアの産前診断の可行性を著しく改善しています.
科学分野:
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
- 血液学 ヘマトロジ
背景:
- ベータ・タラセセミアは,重大な遺伝的血液疾患である.
- 正確な胎児診断は,ベータタラセミアの管理に不可欠です.
- ベータ・グロービン遺伝子クラスターは,遺伝学研究の重要な分野である.
研究 の 目的:
- 新種のAva II制限酵素ポリモルフィズムが,psiβ遺伝子で発生しているかを調査する.
- 地中海の集団におけるベータタラセミアの産前診断におけるこの多形性の有用性を評価する.
主な方法:
- 地中海系ファミリーの染色体でDNA分析を行った.
- Ava IIポリモルフィックサイトの有病率は,ベータタラセミアと正常染色体で決定されました.
- グループ間のポリモルフィズム頻度の統計的比較が行われました.
主要な成果:
- Ava IIポリモルフィックサイトは,正常染色体 (4/120) と比較して,ベータタラセミア染色体 (54/115) で著しく少ないことが判明しました.
- アレル周波数におけるこの観察された差異は,ポリモルフィズムとベータタラセミアの強い関連性を示している.
結論:
- 特定されたAva IIポリモルフィズムであるpsiβ遺伝子は,貴重な遺伝子マーカーである.
- このマーカーは,研究対象集団におけるDNA分析を通じてベータタラセミアの産前診断の実現可能性を大幅に高めます.
さらに関連する動画
10:27Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria
Published on: November 10, 2015
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
関連する概念動画
Pedigree Analysis
Overview
Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
